Which colon cancer screening test? A comparison of costs, effectiveness, and compliance

American Journal of Medicine

Volumn 111, Issue 8, 2001, Pages 593-601

  Vijan, Sandeep ^a,b   Hwang, Erica W ^c   Hofer, Timothy P ^a,b   Hayward, Rodney A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL PRACTICE; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PATIENT COMPLIANCE; POLYP; PRIORITY JOURNAL; SCREENING TEST; SIGMOIDOSCOPY;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONOSCOPY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; GUIDELINE ADHERENCE; HUMANS; MARKOV CHAINS; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SURVIVAL ANALYSIS;

EID: 0035697999     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00977-9     Document Type: Article

References (72)

1. Cancer statistics, 1996
2. Reducing mortality from colorectal cancer by screening for fecal occult blood
3. Randomised study of screening for colorectal cancer with faecal-occult blood test
4. Randomised controlled trial of faecal-occult blood screening for colorectal cancer
5. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
6. Screening sigmoidoscopy and colorectal cancer mortality
7. Cost effectiveness of colorectal cancer screening in average-risk adults
8. Cost effectiveness of colon cancer screening
9. Cost effectiveness model for colon cancer screening
10. Cost effectiveness of screening for colorectal cancer in the general population
11. Cost effectiveness of colonoscopy in screening for colorectal cancer
12. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer
13. Colorectal cancer screening: Clinical guidelines and rationale
14. Cost effectiveness of colorectal cancer screening in the elderly
15. Screening for colorectal cancer
16. Endoscopic colorectal cancer screening: A cost-saving analysis
17. A decision model and cost effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults
18. Has the use of cervical, breast, and colorectal cancer screening increased in the United States?
19. The knowledge and use of screening tests for colorectal and prostate cancer: Data from the 1987 National Health Interview Survey
20. Flexible sigmoidoscopy or colonoscopy for colorectal screening: A randomized trial of performance and acceptability
21. Endoscopic colon screening: Is less more?
22. Low-cost, office-based, screening colonoscopy
23. Prevention of colorectal cancer by colonoscopic polypectomy
24. The evolution of cancer of the colon and rectum
25. Remnants of adenomas in colorectal carcinomas
26. The evolution of colorectal carcinoma
27. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk
28. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men
29. Adenomatous lesions of the large bowel: An autopsy survey
30. Polyps of the colon and rectum: Incidence and distribution
31. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations
32. Cancer patient survival rates: SEER program results for 10 years of follow-up
33. Accuracy of fecal occult blood screening for colorectal neoplasia
34. Sensitivity, specificity, and positive predictivity of the hemoccult test in screening for colorectal cancers
35. Relationship between patterns of bleeding with hemoccult sensitivity in patients with colorectal cancers or adenomas
36. Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia
37. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests
38. Hemoccult screening in detecting colorectal neoplasm: Sensitivity, specificity, and predictive value
39. Sensitivity, specificity, and predictive value of fecal occult blood testing (hemoccult II) for colorectal neoplasia in symptomatic patients: A prospective study with total colonoscopy
40. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men
41. Screening for colon malignancy with colonoscopy
42. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas
43. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
44. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps
45. Colonoscopy: A review of its yield for cancers and adenomas by indication
46. Sensitivity of screening sigmoidoscopy for proximal colorectal tumours
47. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy?
48. Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients
49. Complications and hazards of gastrointestinal endoscopy
50. Towards safer colonoscopy: A report on the complications of 5000 diagnostic or therapeutic colonoscopies
51. Colonoscopy: A prospective report of complications
52. Screening for colorectal cancer in a high-risk population
53. Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2000 and physician volume performance standard rates of increase for federal fiscal year 1999, notice
54. Cost of care for cancer in a health maintenance organization
55. Analysis of the continuous Medicare history sample file: The cost of treating cancer
56. Flexible sigmoidoscopy in asymptomatic patients with negative fecal occult blood tests
57. A normal initial colonoscopy after age 50 does not predict a polyp-free status for life
58. 5-Year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons
59. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination
60. Polyp guideline: Diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps
61. Follow-up after polypectomy: Consensus?
62. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
63. Screening colonoscopy: The cost of common sense
64. Screening colonoscopy: Has the time come?
65. Screening colonoscopy: Has the time come?
66. Using colonoscopy to screen for colorectal cancer
67. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997
68. The end of barium enemas?
69. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy
70. Cost effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age